ANDA 75160, held by Hospira. Metoprolol Tartrate.
As of Nov 22, 2026, ANDA 75160 (Metoprolol Tartrate), held by Hospira, was first approved by FDA on Jul 6, 1998, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 6, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoprolol Tartrate1MG/ML · injectable;injection | Metoprolol Tartrate | Discontinued |
| Jun 9, 2021 | Supplement 21Labeling · Standard review | Approved | None posted |
| Dec 30, 2015 | Supplement 15Labeling · Standard review | Approved | None posted |
| Feb 27, 2013 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 11, 2010 | Supplement 13Labeling | Approved | None posted |
| Nov 4, 2008 | Supplement 12Labeling | Approved | None posted |
| Apr 28, 2008 | Supplement 10Labeling | Approved | None posted |
| May 15, 2002 | Supplement 5Manufacturing | Approved | None posted |
| May 15, 2002 | Supplement 4Manufacturing | Approved | None posted |
| May 15, 2002 | Supplement 3Manufacturing | Approved | None posted |
| May 15, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Sep 17, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Jul 6, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters